Reoxygenation using a novel CO2 therapy decreases the metastatic potential of osteosarcoma cells
Abstract Osteosarcoma is the most common primary solid malignant bone tumor. Despite substantial improvements in surgery and chemotherapy, metastasis remains a major cause of fatal outcomes, and the molecular mechanisms